Carcinogenicity of Talc and Acrylonitrile
Public Domain
-
2024/08/01
-
Details
-
Personal Author:Ahmadi A ; Benbrahim-Tallaa L ; Blanco J ; Cardenas A ; Carreon-Valencia, Tania ; Chittiboyina S ; Consonni D ; Davies L ; de Conti A ; De Matteis S ; Demers PA ; Facchin C ; Felley-Bosco E ; Fritz JM ; Ghio AJ ; Göen T ; Grosse Y ; Gualtieri AF ; Josephy PD ; Koutros S ; Kulasingam S ; Kunzmann A ; Linhart I ; Louro H ; MacLehose R ; Madia F ; Mattock H ; Motlhale M ; O'Brien KM ; Panzacchi S ; Pasqual E ; Peña L ; Rössner P ; Schildkraut JM ; Schubauer-Berigan, Mary K. ; Shah S ; Sim, Malcolm R. ; Stayner, Leslie T. ; Stefaniak, Aleksandr B. ; Stewart P ; Suonio E ; Tsuda H ; Wedekind R ; Wentzensen N ; Wild P ; Xu Y
-
Description:In June, 2024, a Working Group of 29 scientists from 13 countries met at the International Agency for Research on Cancer (IARC) in Lyon, France, to finalise their evaluation of the carcinogenicity of talc and acrylonitrile. Acrylonitrile was classified as "carcinogenic to humans" (Group 1) based on "sufficient" evidence for cancer in humans. There was also "sufficient" evidence for cancer in experimental animals and "strong" mechanistic evidence in experimental systems. Talc was classified as "probably carcinogenic to humans" (Group 2A) based on a combination of "limited" evidence for cancer in humans, "sufficient" evidence for cancer in experimental animals, and "strong" mechanistic evidence in human primary cells and experimental systems. This evaluation supersedes the previous classifications of "talc not containing asbestos or asbestiform fibres" and "perineal use of talc-based body powder" in Volume 93 of the IARC Monographs. These assessments will be published in Volume 136 of the IARC Monographs. "Talc containing asbestos" was not re-evaluated and retains its classification within "asbestos" (Group 1) from Volume 100C. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1470-2045
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:25
-
Issue:8
-
NIOSHTIC Number:nn:20070348
-
Citation:Lancet Oncol 2024 Aug; 25(8):962-963
-
CAS Registry Number:
-
Federal Fiscal Year:2024
-
Peer Reviewed:False
-
Source Full Name:The Lancet Oncology
-
Collection(s):
-
Main Document Checksum:urn:sha-512:b84005ecfc62377549691b18c8ecc1a231d1a12c1954154fda9c91fbf1c4dd4a1b8547ad61c59abb47c205e41d483c3ef1676148a34bf134b015b56477f32d7c
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like